Oscar Health, Inc. (OSCR) Current Ratio
- Current ratio · latest quarter: Value 1.08×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 1.08× | Current assets / current liabilities. $9.37B ÷ $8.69B ≈ 1.08× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 9.37B USD | Assets, Current |
| Current obligations | 8.69B USD | Liabilities, Current |
| Cash and equivalents | 4.08B USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 4.48B USD | Debt Securities, Available-for-sale, Current |
| Customer receivables | 380.06M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | |
| Payables | (m) | |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $9.37B | $8.69B | $4.08B | $4.48B | $380.06M | (m) | (m) | (m) | 1.08× |
| 2026-03-31 | $7.78B | $7.14B | $4.81B | $1.99B | $587.02M | (m) | (m) | (m) | 1.09× |
| 2025-12-31 | $4.61B | $4.86B | $2.77B | $1.22B | $362.68M | (m) | (m) | (m) | 0.95× |
| 2025-09-30 | $3.76B | $3.98B | $2.15B | $887.59M | (m) | (m) | (m) | (m) | 0.95× |
| 2025-06-30 | $4.31B | $4.87B | $2.60B | $938.10M | (m) | (m) | (m) | (m) | 0.89× |
| 2025-03-31 | $3.77B | $4.15B | $2.24B | $751.49M | (m) | (m) | (m) | (m) | 0.91× |
| 2024-12-31 | $2.85B | $3.46B | $1.53B | $624.46M | (m) | (m) | (m) | (m) | 0.82× |
| 2024-09-30 | $2.37B | $2.95B | $1.21B | $503.78M | (m) | (m) | (m) | (m) | 0.80× |
| 2024-06-30 | $3.36B | $3.50B | $2.27B | $363.64M | (m) | (m) | (m) | (m) | 0.96× |
| 2024-03-31 | $3.50B | $3.02B | $2.23B | $616.13M | (m) | (m) | (m) | (m) | 1.16× |
| 2023-12-31 | $3.06B | $2.43B | $1.87B | (m) | (m) | (m) | (m) | (m) | 1.26× |
| 2023-09-30 | $2.99B | $2.06B | $1.40B | $1.04B | (m) | (m) | (m) | (m) | 1.45× |
| 2023-06-30 | $4.19B | $3.24B | $2.32B | $1.26B | (m) | (m) | (m) | (m) | 1.29× |
| 2023-03-31 | $4.13B | $3.18B | $2.11B | $1.32B | (m) | (m) | (m) | (m) | 1.30× |
| 2022-12-31 | $4.12B | $3.26B | $1.56B | $1.40B | (m) | (m) | (m) | (m) | 1.26× |
| 2022-09-30 | $3.93B | $2.85B | $2.11B | $718.23M | (m) | (m) | (m) | (m) | 1.38× |
| 2022-06-30 | $4.26B | $3.13B | $2.36B | $909.01M | (m) | (m) | (m) | (m) | 1.36× |
| 2022-03-31 | $3.67B | $2.64B | $2.07B | $810.00M | (m) | (m) | (m) | (m) | 1.39× |
| 2021-12-31 | $2.31B | $1.85B | $1.10B | $587.09M | (m) | (m) | (m) | (m) | 1.24× |
| 2021-09-30 | $2.24B | $1.62B | $1.08B | $586.95M | (m) | (m) | (m) | (m) | 1.39× |
| 2021-06-30 | $2.82B | $1.97B | $1.67B | $614.98M | (m) | (m) | (m) | (m) | 1.43× |
| 2021-03-31 | $3.18B | $1.81B | $2.32B | $389.02M | (m) | (m) | (m) | (m) | 1.76× |
| 2020-12-31 | $1.87B | $1.67B | $826.33M | $366.39M | (m) | (m) | (m) | (m) | 1.12× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.